Ratings on (KSS) (LL) (LXRX) (MCD) (MDMD) Reiterated

Ratings on shares of Kohls Corp (NYSE:KSS), Lumber Liquidators (NYSE: LL), Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), McDonald’s (NYSE: MCD) and Mediamind Technologies (NASDAQ: MDMD) were reiterated by analysts.

Jefferies (NYSE:JEF) reiterated a “buy” rating on Kohls Corp (KSS). They have a price target $63.00 on the company.

Goldman Sachs (NYSE:GS) reiterated a “neutral” rating on Lumber Liquidators (LL).

JPMorgan Chase & Co. (NYSE:JPM) reiterated an “overweight” rating on Lexicon Pharmaceuticals, Inc. (LXRX).

Morgan Stanley (NYSE:MS) reiterated an “equal weight” rating on McDonald’s (MCD).

Deutsche Bank (NYSE:DB) reiterated a “buy” rating on Mediamind Technologies (MDMD). They have a price target of $17.00 on the company.

Medifast (MED) (ATHN) (GRT) LXRX) - New Ratings and Price Targets

New ratings and price targets on Medifast, Inc. (NYSE: MED), AthenaHealth (NASDAQ: ATHN), Glimcher Realty Trust (NYSE: GRT) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).

Oppenheimer initiated coverage on AthenaHealth (ATHN). They placed an “Underperform” rating and a price target of $30.00 on the firm.

Goldman Sachs (NYSE:GS) initiated coverage on Glimcher Realty Trust (GRT). They placed a “Neutral” rating on the stock.

Wedbush initiated coverage on Lexicon Pharmaceuticals, Inc. (LXRX). They placed an “Outperform” rating and a price target of $3.00 on the company.

Capstone initiated coverage on Medifast, Inc. (MED). They placed a “Buy” rating on the shares.